4,279 Shares in CVS Health Corporation $CVS Purchased by Vestmark Advisory Solutions Inc.

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Vestmark Advisory Solutions Inc. bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,279 shares of the pharmacy operator's stock, valued at approximately $290,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CVS. Ossiam grew its stake in shares of CVS Health by 45.8% in the fourth quarter. Ossiam now owns 33,586 shares of the pharmacy operator's stock worth $1,508,000 after purchasing an additional 10,553 shares during the last quarter. MetLife Investment Management LLC grew its stake in shares of CVS Health by 1.8% in the fourth quarter. MetLife Investment Management LLC now owns 333,134 shares of the pharmacy operator's stock worth $14,954,000 after purchasing an additional 5,964 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in shares of CVS Health by 40.1% in the fourth quarter. Tower Research Capital LLC TRC now owns 70,218 shares of the pharmacy operator's stock worth $3,152,000 after purchasing an additional 20,107 shares during the last quarter. State of Tennessee Department of Treasury grew its stake in shares of CVS Health by 4.7% in the fourth quarter. State of Tennessee Department of Treasury now owns 477,251 shares of the pharmacy operator's stock worth $21,424,000 after purchasing an additional 21,251 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of CVS Health by 14.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,366,403 shares of the pharmacy operator's stock worth $600,019,000 after purchasing an additional 1,660,321 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 0.4%

Shares of NYSE CVS traded down $0.2560 during trading on Friday, hitting $71.1740. 6,982,068 shares of the company traded hands, compared to its average volume of 8,748,738. The business's fifty day moving average is $65.50 and its 200 day moving average is $65.11. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The firm has a market capitalization of $90.27 billion, a price-to-earnings ratio of 19.88, a P/E/G ratio of 0.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. During the same quarter in the prior year, the business earned $1.83 earnings per share. The business's quarterly revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date was Tuesday, July 22nd. CVS Health's dividend payout ratio is currently 74.30%.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction that occurred on Thursday, June 5th. The shares were bought at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the acquisition, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.22% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on CVS shares. Baird R W raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 14th. Wells Fargo & Company reissued an "overweight" rating and issued a $84.00 price objective (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Royal Bank Of Canada boosted their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, UBS Group raised CVS Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $67.00 to $79.00 in a research note on Monday, August 18th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, CVS Health presently has a consensus rating of "Buy" and an average price target of $76.67.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.